SBIR/STTR Research Award
Feasibility of early detection of infection and sepsis in the home
Award amount
$484,353Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NIGHTINGALE LABS CORP
- Proposal award date
- 2023-07-10
- Contract end date
- 2025-06-30
- UEI
- NA22L1MU93F1
- Solicitation number
- PA22-176
- Topic code
- NIAID
Research abstract
PROJECT ABSTRACT Sepsis, the systemic manifestation of infection, causes complex and costly hospitalizations with unacceptably high morbidity and mortality. Most research focuses on detection of the sepsis within the hospital; however, most sepsis is community-acquired and thus begins in the home. Nightingale Labs has developed a fully automated non-contact home bed sensing platform that detects signatures of hospitalizations without requiring any patient participation. Here, we will test whether the technology can be used to detect infections or sepsis. This SBIR proposal will evaluate the feasibility (Phase 1) and execute (Phase 2) a prospective observational study to learn the signatures of impending hospitalizations for localized or systemic infection. The work will substantially expand the toolkit for facilitating early recognition and intervention to reduce infection- and sepsis-associated morbidity and mortality.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.